Elevance Health Inc (NYSE: ELV) on Monday, soared 4.02% from the previous trading day, before settling in for the closing price of $381.15. Within the past 52 weeks, ELV’s price has moved between $362.21 and $567.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 13.27% over the last five years. The company achieved an average annual earnings per share of -0.53%. With a float of $231.43 million, this company’s outstanding shares have now reached $231.93 million.
The firm has a total of 104900 workers. Let’s measure their productivity. In terms of profitability, gross margin is 27.94%, operating margin of 5.29%, and the pretax margin is 4.77%.
Elevance Health Inc (ELV) Insider Activity
Observing investor behavior towards Healthcare Plans industry stocks is more important than anything else. The insider ownership of Elevance Health Inc is 0.21%, while institutional ownership is 90.31%. The most recent insider transaction that took place on Oct 18 ’24, was worth 3,205,182. In this transaction EVP & President, Commercial of this company sold 7,417 shares at a rate of $432.14, taking the stock ownership to the 8,423 shares. Before that another transaction happened on Oct 18 ’24, when Company’s Director proposed sale 7,417 for $432.28, making the entire transaction worth $3,206,221.
Elevance Health Inc (ELV) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 10.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.01% during the next five years compared to 12.18% growth over the previous five years of trading.
Elevance Health Inc (NYSE: ELV) Trading Performance Indicators
Elevance Health Inc (ELV) is currently performing well based on its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.53. Likewise, its price to free cash flow for the trailing twelve months is 105.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 27.43, a number that is poised to hit 3.98 in the next quarter and is forecasted to reach 34.58 in one year’s time.
Technical Analysis of Elevance Health Inc (ELV)
Analysing the last 5-days average volume posted by the [Elevance Health Inc, ELV], we can find that recorded value of 1.68 million was better than the volume posted last year of 1.55 million. As of the previous 9 days, the stock’s Stochastic %D was 82.37%. Additionally, its Average True Range was 9.47.
During the past 100 days, Elevance Health Inc’s (ELV) raw stochastic average was set at 16.72%, which indicates a significant decrease from 94.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.90% in the past 14 days, which was lower than the 28.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $393.39, while its 200-day Moving Average is $489.85. Now, the first resistance to watch is $402.89. This is followed by the second major resistance level at $409.30. The third major resistance level sits at $420.16. If the price goes on to break the first support level at $385.62, it is likely to go to the next support level at $374.76. Should the price break the second support level, the third support level stands at $368.35.
Elevance Health Inc (NYSE: ELV) Key Stats
Market capitalization of the company is 91.96 billion based on 231,923K outstanding shares. Right now, sales total 171,340 M and income totals 5,987 M. The company made 45,106 M in profit during its latest quarter, and 1,016 M in sales during its previous quarter.
